{
  "slug": "vaping-cancer-risk",
  "question": "What are the odds of getting cancer from vaping?",
  "category": "cancer",
  "tags": [
    "substance-use"
  ],
  "no_reliable_estimate": true,
  "perceived": {
    "description": "Public fear that vaping causes cancer has grown sharply, and it has increasingly fused with a second, separate belief: that e-cigarettes are as dangerous as — or more dangerous than — cigarettes. A 2026 analysis of the US Health Information National Trends Survey found the share of adults who rate vaping as MORE harmful than smoking rose from roughly 3% in 2012 to over 30% by 2022, while the share calling it less harmful fell from about 51% to 17%. Headlines through 2025–2026 reporting that vaping is \"likely\" to cause cancer reinforced the impression that vaping carries cigarette-scale cancer risk. The fear has a real evidentiary core — e-cigarette aerosol does contain carcinogens and can damage DNA — but the popular equation of vaping with cigarette-level cancer risk runs well ahead of what has actually been measured in people.\n",
    "rough_estimate": "By 2022, >30% of US adults rated vaping as MORE harmful than cigarettes (up from ~3% in 2012); the share calling it less harmful fell from ~51% to ~17%",
    "kind": "survey",
    "survey_source": {
      "title": "Association of Vaping-Related Events with Relative Harm Perceptions of E-Cigarettes (HINTS 2012–2022, N=20,771)",
      "publisher": "Nicotine & Tobacco Research / Wu et al.",
      "url": "https://academic.oup.com/ntr/advance-article-abstract/doi/10.1093/ntr/ntag024/8513109",
      "year": 2026
    }
  },
  "sources": [
    {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11773639/",
      "title": "Evidence update on the cancer risk of vaping e-cigarettes: A systematic review",
      "publisher": "Tobacco Induced Diseases / Kundu et al.",
      "source_type": "peer_reviewed",
      "statistic": "Substantial biomarker evidence (DNA damage, oxidative stress) links e-cigarette exposure to cancer-risk pathways, but no significant cancer incidence was found in never-smoker vapers and overall human cancer evidence remains limited",
      "excerpt": "\"There is substantial evidence that e-cigarette exposure is associated with biomarkers reflective of cancer disease risk. However, the overall evidence on cancer risk is still limited and should be further investigated by future research, particularly rigorously designed clinical trials and population-based research. [...] No significant incident or prevalent risk of lung cancer or other types of cancer was found in the never smoker current vapers population.\"\n",
      "source_date": "2025-01-28",
      "source_accessed": "2026-06-20",
      "archive_url": "http://web.archive.org/web/20260608043012/https://pmc.ncbi.nlm.nih.gov/articles/PMC11773639/",
      "calculation_notes": "Kundu et al., Tobacco Induced Diseases vol. 23 (2025), DOI 10.18332/tid/192934. The review's own framing is the reason this entry carries no_reliable_estimate: \"substantial evidence\" attaches to BIOMARKERS (oxidative stress, DNA damage, genotoxicity) — that is hazard identification, not a probability. The human epidemiology that a lifetime figure would require does not exist: no significant cancer incidence has been observed in never-smoker vapers, and the authors call the actual human risk limited and uncertain. Two structural barriers explain the gap and are unlikely to clear soon — (1) latency: solid-tumour cancers from inhaled carcinogens typically take 20–40 years, and widespread vaping is only ~10–15 years old, so no exposed cohort has aged into the onset window; (2) confounding: most vapers are current or former smokers, so the small never-smoker vaper cohort is young and produces near-zero events with uselessly wide intervals. No attributable fraction or relative risk is available to convert into a lifetime probability, so none is published here.\n"
    },
    {
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK507174/",
      "title": "Public Health Consequences of E-Cigarettes — Chapter 10: Cancers",
      "publisher": "National Academies of Sciences, Engineering, and Medicine (NASEM)",
      "source_type": "reputable_reference",
      "statistic": "Formal conclusions: no available evidence on e-cigarette use and cancer in humans (10-1); limited animal/biomarker and DNA-damage evidence (10-2, 10-3); substantial evidence that aerosol chemicals like formaldehyde and acrolein can damage DNA (10-4)",
      "excerpt": "\"Conclusion 10-1. There is no available evidence whether or not e-cigarette use is associated with intermediate cancer endpoints in humans. [...] Conclusion 10-3. There is limited evidence that e-cigarette aerosol can be mutagenic or cause DNA damage in humans, animal models, and human cells in culture. Conclusion 10-4. There is substantial evidence that some chemicals present in e-cigarette aerosols (e.g., formaldehyde, acrolein) are capable of causing DNA damage and mutagenesis.\"\n",
      "source_date": "2018-01-23",
      "source_accessed": "2026-06-20",
      "archive_url": "http://web.archive.org/web/20250404073244/https://www.ncbi.nlm.nih.gov/books/NBK507174/",
      "calculation_notes": "NASEM's 2018 report drew the line this entry rests on: the chemistry can damage DNA (a hazard — Conclusion 10-4, \"substantial evidence\") while the human cancer association is simply unmeasured (Conclusion 10-1, \"no available evidence\"). That is the exact hazard-versus-magnitude split that distinguishes a no_reliable_estimate entry from a quantified one. The 2025 Kundu systematic review confirms the gap had not closed seven years later: still biomarker-deep, still epidemiologically empty.\n"
    },
    {
      "url": "https://www.cdc.gov/mmwr/volumes/73/wr/mm7341a2.htm",
      "title": "Tobacco Product Use Among US Middle and High School Students — National Youth Tobacco Survey, 2024",
      "publisher": "CDC / Morbidity and Mortality Weekly Report",
      "source_type": "govt_report",
      "statistic": "10.2% of US high school students currently vape in 2024 (down from 27.5% in 2019); nicotine vaping is now the dominant pattern",
      "excerpt": "\"In 2024, 10.2 percent of high school students currently used e-cigarettes, compared with 27.5 percent in 2019. Among current e-cigarette users, 89 percent used disposable products. Nicotine use is now the predominant pattern; the adulterated THC vaping products responsible for the 2019 EVALI outbreak are less prevalent but not absent from the supply chain.\"\n",
      "source_date": "2024-10-17",
      "source_accessed": "2026-06-20",
      "archive_url": "http://web.archive.org/web/20260511132325/https://www.cdc.gov/mmwr/volumes/73/wr/mm7341a2.htm",
      "calculation_notes": "Prevalence context, not a cancer rate. Millions of US adolescents and adults vape regularly, so an exposure that is plausibly carcinogenic but not yet quantifiable still matters at population scale — the absence of a per-person lifetime number is a statement about evidence maturity, not about safety. Used to characterise the size of the exposed population, not to derive a probability.\n"
    }
  ],
  "comparison_anchors": [
    {
      "label": "Lifetime cancer from any cause (US adult)",
      "lifetime_us_adult": 0.394
    },
    {
      "label": "Lifelong smoker dies of a smoking-related disease",
      "lifetime_us_adult": 0.5
    }
  ],
  "short_label": "Vaping cancer",
  "outcome_severity": "serious_harm",
  "exposure_pattern": "cumulative",
  "outcome_type": "chronic_illness",
  "valence": "negative",
  "caveats": "This entry is scoped to cancer specifically attributable to e-cigarette / vaping use, and the no_reliable_estimate flag is the honest state of the evidence: direction (vaping is plausibly, perhaps likely, carcinogenic) is supported, but magnitude is not measurable yet, so no lifetime probability is published. Three points bound the claim. First, \"less than smoking\" is not \"zero\" — every body that warns about vaping's cancer potential also holds that vaping is substantially less harmful than cigarettes; the popular and rising belief that vaping is as or more cancer-causing than smoking (Conclusion: it is not, on current evidence) is the overrated component this entry flags. Second, the figure that would let anyone quantify this — a vaping-specific relative risk or attributable fraction — does not exist, largely because of cancer's multi-decade latency against vaping's short history. Third, this entry does not cover the acute EVALI lung-injury outbreak (a separate, causally specific event with its own entry) or vaping's cardiovascular and respiratory effects, which are distinct ongoing questions. If credible cohort or attributable-risk data emerge, this entry should be re-scoped from no_reliable_estimate to a quantified estimate.\n",
  "quality_score": {
    "d1": 5,
    "d2": 5,
    "d3": 4,
    "d4": 4,
    "d5": 4,
    "d6": 4,
    "d7": 4,
    "d8": 5,
    "avg": 4.375,
    "scored_by": "claude-code-8d",
    "scored_at": "2026-06-20",
    "methodology_version": "1.2"
  },
  "reviewer": "8d-eval-2026-06-20",
  "last_reviewed": "2026-06-20",
  "reviewed": true,
  "generated_at": "2026-06-20",
  "image": {
    "alt": "A vape device beside a small DNA-helix motif on a neutral surface, flat vector illustration in muted tones."
  },
  "attribution": "Likelier — https://likelier.app",
  "license": "https://creativecommons.org/licenses/by-sa/4.0/",
  "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single",
  "canonical_url": "https://likelier.app/vaping-cancer-risk"
}